×
Natera Common Stock Net 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera common stock net for the quarter ending June 30, 2024 was
$0.000B
, a
9.09% increase
year-over-year.
Natera common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Natera common stock net for 2022 was
$0B
, a
10% increase
from 2021.
Natera common stock net for 2021 was
$0B
, a
11.11% increase
from 2020.
View More
Natera Common Stock Net 2014-2024 | NTRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Natera common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Natera common stock net for 2022 was
$0B
, a
10% increase
from 2021.
Natera common stock net for 2021 was
$0B
, a
11.11% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$98B
Cencora (COR)
$48.9B
DiDi Global (DIDIY)
$23.6B
ICON (ICLR)
$17.7B
Viatris (VTRS)
$15.5B
Avantor (AVTR)
$15.4B
Revvity (RVTY)
$14.9B
BioMerieux (BMXMF)
$13.1B
CochLear (CHEOY)
$12.6B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.3B
Charles River Laboratories (CRL)
$11B
Doximity (DOCS)
$10.8B
HealthEquity (HQY)
$8.6B
Sonic Healthcare (SKHHY)
$8.5B
Bausch + Lomb (BLCO)
$7B
Life Times (LTH)
$5.2B
Sotera Health (SHC)
$4.6B
Organon (OGN)
$4.1B
Surgery Partners (SGRY)
$3.9B
BrightSpring Health Services (BTSG)
$3.4B
PACS (PACS)
$3.3B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B
Teladoc Health (TDOC)
$1.6B